The past year marked a proverbial inflection point for organoid models designed to uncover biological insights previously unattainable through traditional…

Eric Green, MD, PhD, Chief Medical Officer of Illumina, was awarded the Distinguished Service Award by board members of The…

Credit: koto_feja / iStock / Getty Images Plus Interfacing biological tissues in the brain with electronic systems seems like science…

Credit: Marcin Klapczynski/Getty Images Researchers at Johns Hopkins University and the University of Maryland School of Pharmacy have developed a…

Mike GarrettCEO, Taconic Biosciences FDA guidance encouraging reduced reliance on animal models in preclinical research reflects a well-intentioned push toward…

Since the FDA’s April 2025 announcement to phase out required animal testing in favor of human-first preclinical models for monoclonal…

Antibody-drug conjugates (ADCs) have evolved from an elegant scientific concept into one of oncology’s most dynamic therapeutic classes. By fusing…

Campbell Bunce, PhD Chief Scientific OfficerAbzena Over the past decade, biologics development has moved from artisanal experimentation to a data-driven,…

Antibody-drug conjugates (ADCs) constitute a rapidly evolving class of targeted oncology therapeutics that couple tumor-selective antibodies with highly potent cytotoxins.…